The following information comes from a study published in the July 27, 2009 issue of the Archives of Internal Medicine.
The percentages of complications in well controlled type 1s were very impressive.
“The demonstration that near-normal glucose control substantially lowers microvascular and cardiovascular complications has heralded a new era of Type 1 diabetes care,” says lead author David M. Nathan, M.D., of Massachusetts General Hospital. “The remarkable improvement in long-term outcomes achieved with intensive glucose control should encourage clinicians and patients alike to implement intensive therapy as early in the course of Type 1 diabetes as possible.”
The authors compared overall rates of eye, kidney, and cardiovascular complications in three groups of people diagnosed with Type 1 diabetes an average of 30 years earlier.
“After 30 years of diabetes, fewer than 1% of those receiving intensive glucose control in the DCCT had significantly impaired vision, kidney failure, or needed a limb amputation due to diabetes,” noted Saul Genuth, M.D., of Case Western University, who co-chairs the EDIC study. “Tight control is difficult to achieve and maintain, but its benefits have changed the course of diabetes.” Intensive treatment meant trying to keep hemoglobin A1c readings at 6% or less with at least three insulin injections a day or an insulin pump.